These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 12086873)

  • 1. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation.
    Kolligs FT; Nieman MT; Winer I; Hu G; Van Mater D; Feng Y; Smith IM; Wu R; Zhai Y; Cho KR; Fearon ER
    Cancer Cell; 2002 Mar; 1(2):145-55. PubMed ID: 12086873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.
    Leung JY; Kolligs FT; Wu R; Zhai Y; Kuick R; Hanash S; Cho KR; Fearon ER
    J Biol Chem; 2002 Jun; 277(24):21657-65. PubMed ID: 11940574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression.
    Kolligs FT; Hu G; Dang CV; Fearon ER
    Mol Cell Biol; 1999 Aug; 19(8):5696-706. PubMed ID: 10409758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
    Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
    Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.
    Ishitani T; Ninomiya-Tsuji J; Matsumoto K
    Mol Cell Biol; 2003 Feb; 23(4):1379-89. PubMed ID: 12556497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling.
    Brantjes H; Barker N; van Es J; Clevers H
    Biol Chem; 2002 Feb; 383(2):255-61. PubMed ID: 11934263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIP49 regulates beta-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling.
    Feng Y; Lee N; Fearon ER
    Cancer Res; 2003 Dec; 63(24):8726-34. PubMed ID: 14695187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
    Adachi S; Jigami T; Yasui T; Nakano T; Ohwada S; Omori Y; Sugano S; Ohkawara B; Shibuya H; Nakamura T; Akiyama T
    Cancer Res; 2004 Dec; 64(23):8496-501. PubMed ID: 15574752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCF transcription factors: molecular switches in carcinogenesis.
    Roose J; Clevers H
    Biochim Biophys Acta; 1999 Oct; 1424(2-3):M23-37. PubMed ID: 10528152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1.
    Aoki M; Hecht A; Kruse U; Kemler R; Vogt PK
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):139-44. PubMed ID: 9874785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling through beta-catenin and Lef/Tcf.
    Novak A; Dedhar S
    Cell Mol Life Sci; 1999 Oct; 56(5-6):523-37. PubMed ID: 11212302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
    Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
    Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway.
    Wielenga VJ; Smits R; Korinek V; Smit L; Kielman M; Fodde R; Clevers H; Pals ST
    Am J Pathol; 1999 Feb; 154(2):515-23. PubMed ID: 10027409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for a nuclear function of beta-catenin in Wnt signaling.
    Cong F; Schweizer L; Chamorro M; Varmus H
    Mol Cell Biol; 2003 Dec; 23(23):8462-70. PubMed ID: 14612392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.
    Jho EH; Zhang T; Domon C; Joo CK; Freund JN; Costantini F
    Mol Cell Biol; 2002 Feb; 22(4):1172-83. PubMed ID: 11809808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis.
    Kolligs FT; Bommer G; Göke B
    Digestion; 2002; 66(3):131-44. PubMed ID: 12481159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Yin-Yang of TCF/beta-catenin signaling.
    Barker N; Morin PJ; Clevers H
    Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of beta -catenin transformation by the p300 transcriptional coactivator.
    Sun Y; Kolligs FT; Hottiger MO; Mosavin R; Fearon ER; Nabel GJ
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12613-8. PubMed ID: 11050151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1.
    Sampson EM; Haque ZK; Ku MC; Tevosian SG; Albanese C; Pestell RG; Paulson KE; Yee AS
    EMBO J; 2001 Aug; 20(16):4500-11. PubMed ID: 11500377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
    Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
    J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.